New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2014
11:09 EDTTEVA, MYL, KSU, GGBOptions with increasing implied volatility: GGB MYL TEVA KSU
News For GGB;MYL;TEVA;KSU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 23, 2015
08:48 EDTMYLMylan confirms exercise of full call option by independent foundation
Subscribe for More Information
08:34 EDTMYL, TEVAMylan foundation exercises call option to 'level playing field'
08:33 EDTTEVA, MYLMylan foundation says shareholders at risk of Teva takeover
Subscribe for More Information
July 22, 2015
10:06 EDTTEVA, MYLAbbott CEO says supportive of Mylan pursuit of Perrigo
Subscribe for More Information
09:30 EDTTEVA, MYLAbbott CEO says 'pretty alligned' with Mylan so far
July 20, 2015
10:26 EDTTEVALeerink's specialty pharma/generics analyst has analyst/industry conference call
Specialty Pharmaceuticals / Generics Analyst Gerberry, along with MEDACorp Specialists Michael Belliveau, PhD and Shashank Upadhye, JD, discuss the strengths and weaknesses of TEVA's preliminary responses to the IPR challenge on Copaxone 40mg, the likely outcomes for the Copaxone 40mg patent challenge and perspectives on recent updates in the JAZZ Xyrem patent case on an Analyst/Industry conference call to be held on July 22 at 2 pm.
08:38 EDTMYLAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
07:51 EDTKSUKansas City Southern upside attractive, says UBS
Subscribe for More Information
07:33 EDTMYLInternational AIDS Society to hold a conference
Subscribe for More Information
07:30 EDTMYLZoetis 'highly likely' to merge with Bayer unit in 2016, says Jefferies
Subscribe for More Information
July 19, 2015
18:42 EDTGGBGerdau says buyout transactions 'carried out at appropriate prices'
Subscribe for More Information
July 17, 2015
08:38 EDTMYL, TEVALeerink puts 25% odds on Teva, Mylan deal within 12 months
Subscribe for More Information
08:02 EDTKSUKansas City Southern sees system performance improving throughout year
Subscribe for More Information
08:01 EDTKSUKansas City Southern reports Q2 adjusted EPS $1.03, consensus $1.02
Reports Q2 revenue $585.8M, consensus $602.78M. Second quarter revenue declined in all commodity groups except Chemicals & Petroleum, which grew 1%. Energy revenue declined 46% driven by lower volumes in utility coal due to lower natural gas prices and in frac sand volumes as a result of the significant decline in U.S. drilling operations. Overall, carload volumes were 6% lower than in second quarter 2014. Excluding the estimated impacts of lower U.S. fuel prices and peso depreciation, revenue declined 2% compared to the second quarter of 2014.
July 16, 2015
15:02 EDTKSUNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include General Electric (GE), consensus 28c... Honeywell (HON), consensus $1.49... Synchrony Financial (SYF), consensus 62c... SunTrust Banks (STI), consensus 81c... Progressive (PGR), consensus 55c... W.W. Grainger (GWW), consensus $3.05... Kansas City Southern (KSU), consensus $1.02... JB Hunt Transport (JBHT), consensus 90c... Autoliv (ALV), consensus $1.55... Comerica (CMA), consensus 75c... First Horizon (FHN), consensus 20c.
14:25 EDTKSUKansas City Southern technical comments
Subscribe for More Information
10:00 EDTKSUOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:41 EDTKSUKansas City Southern downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Brandon Oglenski downgraded Kansas City Southern to Underweight and other rail names after lowering his rating on the North America Airfreight & Ground Transportation space to Neutral from Positive. The analyst sees a lack of positive catalysts amid softer industrial demand, high relative inventories and U.S. dollar appreciation. He lowered his price target for shares to $93 from $112.
July 15, 2015
10:01 EDTKSUKansas City Southern names Brian Hancock as EVP, CMO
Subscribe for More Information
08:19 EDTKSUCSX quarter likely to be 'least bad' one in rail space, says Stephens
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use